How Do Maois Work And Why Are They Still Used? The Reason

MAOIs were the first antidepressants ever discovered, and they still work when many newer drugs fail. They block an enzyme in the brain called monoamine oxidase, which normally breaks down mood-regulating chemicals like serotonin, norepinephrine, and dopamine. When that enzyme is blocked, those chemicals build up, and that lifting of brain chemistry is what relieves depression. They fell out of favor because of strict food restrictions and dangerous interactions, but modern psychiatrists still turn to them for stubborn depression that has not responded to anything else.

How Do MAOIs Work And Why Are They Still Used? The Reason

Monoamine oxidase inhibitors work by disabling the enzyme that clears away three key neurotransmitters. Serotonin regulates mood and appetite. Norepinephrine affects alertness and energy. Dopamine controls motivation and pleasure. In a depressed brain, these chemical messengers can run low. MAOIs stop the breakdown, so more of each molecule stays available for your neurons to use.

That mechanism is different from most modern antidepressants. SSRIs like fluoxetine block the reuptake of serotonin only. SNRIs block reuptake of serotonin and norepinephrine. MAOIs go further — they hit all three systems at once, and they do it at the enzyme level rather than at the nerve ending level. This broader action is exactly why they can help people who have not improved on other medications.

What Conditions Are MAOIs Prescribed For Today?

Psychiatrists mostly prescribe MAOIs for treatment-resistant depression. That means depression that has not improved after trying at least two or three other antidepressant classes. Some research suggests MAOIs are particularly effective for atypical depression, a subtype marked by increased appetite, excessive sleep, and extreme sensitivity to rejection. Many clinicians also consider them for social anxiety disorder and panic disorder when standard treatments fail.

They are rarely a first-choice medication. The risks require careful management, so doctors reserve them for cases where the potential benefit clearly outweighs the safety concerns. In specialized mood disorder clinics, MAOIs remain an active and respected treatment option.

Why Did MAOIs Fall Out of Favor?

The story starts in the 1950s. Iproniazid was originally developed as a tuberculosis drug, and doctors noticed patients became happier while taking it. That observation launched the antidepressant era. For about two decades, MAOIs were a mainstream treatment. Then the risks became clear.

The enzyme monoamine oxidase also breaks down tyramine, a compound found in aged cheese, cured meats, fermented foods, and some beers. When MAOIs block the enzyme, tyramine builds up to dangerous levels. A sudden surge of tyramine triggers a massive release of norepinephrine, which can cause a hypertensive crisis — a rapid, dangerous spike in blood pressure that can lead to stroke. This is sometimes called the “cheese effect,” and it is the main reason MAOIs lost popularity.

Drug interactions were another major problem. MAOIs could not be combined with many other antidepressants, certain painkillers, cold medicines, or herbal supplements. The combination could cause serotonin syndrome, a potentially fatal condition marked by confusion, rapid heart rate, and muscle rigidity. These restrictions made MAOIs inconvenient and intimidating for both doctors and patients.

Are Older MAOIs Different From Newer Ones?

There are two main types of MAOIs. The older ones — phenelzine, tranylcypromine, and isocarboxazid — block the enzyme permanently and irreversibly. Once the drug binds to the enzyme, that enzyme is destroyed. Your body must make new enzyme molecules, which takes about two weeks. During that time, the dietary restrictions remain fully in force.

A newer option, selegiline, is available as a skin patch. The patch delivers the drug directly through the skin, which means less of it reaches the digestive system. At the lowest patch dose, dietary restrictions may not be needed. This was a significant improvement in safety and convenience. However, selegiline is still a MAOI, and it still carries interaction risks.

Another difference matters clinically. The older MAOIs are irreversible, but selegiline at the patch doses used for depression is also considered irreversible. There is also a reversible MAOI called moclobemide, but it is not approved in the United States. This is an important distinction because some countries use moclobemide with fewer dietary restrictions, and patients in the US may hear about it online and wonder why their doctor will not prescribe it.

What Foods And Medications Must Be Avoided?

The tyramine restriction is the defining feature of MAOI treatment. Patients on irreversible MAOIs must avoid aged cheeses like cheddar, blue cheese, and parmesan. They must avoid cured meats such as salami, pepperoni, and fermented sausages. Sauerkraut, soy sauce, miso, and tap beers are also off-limits. Fresh meats, fresh fish, and most dairy products are generally safe.

The medication list is equally strict. MAOIs cannot be combined with other antidepressants, especially SSRIs or SNRIs, because of serotonin syndrome risk. Certain pain medications, particularly meperidine and tramadol, are dangerous. Over-the-counter cold and cough medicines containing decongestants can cause blood pressure spikes. Even some herbal products, like St. John’s Wort, are unsafe.

Doctors typically require a two-week washout period when switching between MAOIs and other antidepressants. This means stopping one medication and waiting before starting another. The washout protects against dangerous interactions but also means patients may go through a period with no medication at all.

How Do MAOIs Compare To Modern Antidepressants?

Modern antidepressants are not necessarily more effective — they are just safer and easier to use. SSRIs and SNRIs do not require dietary restrictions, and they have fewer dangerous drug interactions. That makes them practical first-line treatments. But effectiveness is a different story.

Some clinical evidence suggests MAOIs may be more effective than SSRIs for atypical depression specifically. Studies have also shown that a significant number of people who fail multiple other antidepressants will respond to a MAOI. This is why they remain in the treatment guidelines as a later-line option rather than being abandoned entirely.

For the right patient, the trade-off makes sense. A person with severe, disabling depression who has tried four medications without relief may find that a MAOI changes their life. The dietary discipline is a real burden, but many patients consider it a small price compared to years of untreated depression.

Are MAOIs Safe To Use Today?

Yes, when used correctly under medical supervision. The risks are well understood, and the precautions are well established. A psychiatrist who prescribes MAOIs will review the food list with the patient, discuss medication interactions, and provide written materials. Patients who follow the rules generally avoid hypertensive crises and serotonin syndrome.

The bigger safety concern is the washout period. Because MAOIs stay in the system for weeks, switching to or from them requires careful timing. This is not something a patient should manage alone. Any change in medication should be directed by a psychiatrist who understands MAOI pharmacology.

It is also worth noting that MAOIs are not addictive. They do not produce a high, and stopping them does not cause withdrawal in the way opioids or benzodiazepines do. The challenge is purely about compliance with dietary and medication restrictions.

Why Do Some Doctors Still Avoid MAOIs?

Lack of familiarity is a major factor. Many psychiatrists trained after the 1980s and have limited experience with MAOIs. Medical school curricula often mention them only briefly, focusing on the risks rather than the benefits. A doctor who has never prescribed a MAOI may be understandably hesitant to start.

There is also a practical issue. MAOIs require more patient education, more follow-up, and more vigilance. In a busy clinic, it is easier to prescribe an SSRI and schedule a follow-up in a month. That convenience factor should not be dismissed — but it also means some patients never hear about a treatment that could genuinely help them.

Patients who feel they have exhausted their options should ask their psychiatrist directly about MAOI therapy. A referral to a mood disorders specialist may be appropriate if the treating doctor is not comfortable with these medications.